23 Jun, 2021

Paper Highlights Role of Neurotoxic Soluble Amyloid Oligomers in Alzheimer’s Pathogenesis

alzheon2021-06-25T15:19:06-04:00June 23rd, 2021|Tags: BioSpace.com|

Read More

9 Mar, 2021

New Drug Approval Could Be on Horizon for Alzheimer’s after 17-Year Drought

alzheon2024-07-29T15:57:00-04:00March 9th, 2021|Tags: BioSpace.com|

Read More

1 Dec, 2020

Potential for an Alzheimer’s Treatment Appears to Be Closer Than Ever

alzheon2020-12-07T09:44:16-05:00December 1st, 2020|Tags: BioSpace.com|

Read More

20 Aug, 2020

NIA Backs Alzheon’s Phase III Alzheimer’s Trial with $47 Million Grant

alzheon2020-08-21T21:40:29-04:00August 20th, 2020|Tags: BioSpace.com|

Read More

26 Jan, 2016

Alzheon Highlighted as One of the “Top 20 Life Science Startups to Watch in the U.S.”

alzheon2019-09-23T12:10:53-04:00January 26th, 2016|Tags: BioSpace.com|

Read More

5 Jan, 2015

Alzheon Announces Patent Allowance in Europe for ALZ-801 in Development for Alzheimer’s Disease

alzheon2019-09-23T12:10:54-04:00January 5th, 2015|Tags: BioSpace.com|

Read More